Shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) have earned an average rating of “Buy” from the fourteen ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and nine have given a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $24.33.

A number of research firms recently issued reports on KTWO. Needham & Company LLC downgraded K2M Group from a “strong-buy” rating to a “buy” rating and decreased their price objective for the stock from $26.00 to $20.00 in a report on Friday, December 8th. Cowen set a $28.00 price objective on K2M Group and gave the stock a “buy” rating in a report on Thursday, August 17th. Zacks Investment Research upgraded K2M Group from a “sell” rating to a “hold” rating in a report on Wednesday. William Blair reiterated an “outperform” rating on shares of K2M Group in a report on Tuesday, October 10th. Finally, Piper Jaffray Companies reiterated an “overweight” rating and set a $28.00 price objective on shares of K2M Group in a report on Tuesday, October 10th.

A number of hedge funds and other institutional investors have recently modified their holdings of KTWO. TimesSquare Capital Management LLC boosted its position in K2M Group by 31.5% during the second quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock valued at $70,352,000 after purchasing an additional 691,000 shares during the last quarter. Elk Creek Partners LLC acquired a new stake in shares of K2M Group in the third quarter valued at approximately $7,836,000. Prudential Financial Inc. acquired a new stake in shares of K2M Group in the second quarter valued at approximately $6,595,000. Artemis Investment Management LLP lifted its position in shares of K2M Group by 255.4% in the second quarter. Artemis Investment Management LLP now owns 316,703 shares of the medical device company’s stock valued at $7,716,000 after buying an additional 227,582 shares during the last quarter. Finally, State Street Corp lifted its position in shares of K2M Group by 39.8% in the second quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock valued at $17,378,000 after buying an additional 203,067 shares during the last quarter. 99.16% of the stock is owned by hedge funds and other institutional investors.

Shares of K2M Group (KTWO) traded down $0.05 during trading on Friday, hitting $17.38. The company’s stock had a trading volume of 180,900 shares, compared to its average volume of 406,566. K2M Group has a 12 month low of $16.44 and a 12 month high of $25.99. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 0.29.

K2M Group (NASDAQ:KTWO) last announced its quarterly earnings results on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.01). K2M Group had a negative return on equity of 16.02% and a negative net margin of 16.22%. The business had revenue of $62.65 million during the quarter, compared to the consensus estimate of $62.69 million. During the same quarter last year, the company earned ($0.19) earnings per share. The firm’s revenue was up 5.6% compared to the same quarter last year. research analysts predict that K2M Group will post -0.86 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/12/15/k2m-group-holdings-inc-ktwo-given-consensus-recommendation-of-buy-by-brokerages.html.

K2M Group Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.